Pulmonx Corp (NASDAQ:LUNG) price on Thursday, July 03, rose 2.21% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.78.
A look at the stock’s price movement, the close in the last trading session was $2.72, moving within a range at $2.74 and $2.8751. The beta value (5-Year monthly) was 0.52. Turning to its 52-week performance, $9.37 and $2.50 were the 52-week high and 52-week low respectively. Overall, LUNG moved -12.58% over the past month.
Pulmonx Corp’s market cap currently stands at around $111.92 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-30.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LUNG is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 3 recommend LUNG as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
LUNG’s current price about -2.96% and -17.46% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.83, while 7-day volatility ratio is 5.88% and 6.90% in the 30-day chart. Further, Pulmonx Corp (LUNG) has a beta value of 0.44. Analysts have given the company’s stock an average 52-week price target of $10, forecast between a low of $6 and high of $20. Looking at the price targets, the low is -115.83% off current price level while to achieve the yearly target high, price needs to move -619.42%. Nonetheless, investors will most likely welcome a -259.71% jump to $10 which is the analysts’ median price.
If we refocus on Pulmonx Corp (NASDAQ:LUNG), historical trading data shows that trading volumes averaged 0.26 over the past 10 days and 376.75K over the past 3 months. The company’s latest data on shares outstanding shows there are 40.25 million shares.
The 12.58% of Pulmonx Corp’s shares are in the hands of company insiders while institutional holders own 85.56% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.42 million on 2025-06-13, giving us a short ratio of 3.78. The data shows that as of 2025-06-13 short interest in Pulmonx Corp (LUNG) stood at 519.0 of shares outstanding, with shares short falling to 1.56 million registered in 2025-05-15. Current price change has pushed the stock -55.45% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LUNG stock continues to rise going into the next quarter.
